Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]

  3. Bausch & Lomb - Wikipedia

    en.wikipedia.org/wiki/Bausch_&_Lomb

    Bausch & Lomb (since 2010 stylized as Bausch + Lomb[2]) is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, [3] lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. [4][5] The company was founded in Rochester, New ...

  4. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [4][5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to ...

  5. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  6. Novartis Obtains Final Shares of Alcon for $12.9 Billion - AOL

    www.aol.com/2010/12/15/novartis-obtains-final...

    Shares of Novartis (NVS) soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon (ACL) for $12.9 billion. Novartis had been trying to gain ...

  7. Novartis Aims to Beat $1.9B in Cost Savings By Year's End - AOL

    www.aol.com/news/2011-09-13-novartis-aims-to...

    Novartis (NYS: NVS) has two things to say. It now expects more bang for its buck from Alcon. The eye-care acquisition, which cost Novartis $51 billion, will deliver high single-digit to low double ...

  8. Ciprofloxacin/dexamethasone - Wikipedia

    en.wikipedia.org/wiki/Ciprofloxacin/dexamethasone

    In clinical trials, the median time to cessation of ear pain in Ciprodex was five days in a sample population of 909 participants. However, the clinical trial failed to demonstrate any significant benefit of using the combination of active ingredients in Ciprodex over ciprofloxacin alone, in regards to ear pain.

  9. List of pharmaceutical companies - Wikipedia

    en.wikipedia.org/wiki/List_of_pharmaceutical...

    This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.